Current state of transcatheter tricuspid valve repair

Dhaval Kolte, Sammy Elmariah, Dhaval Kolte, Sammy Elmariah

Abstract

Tricuspid regurgitation (TR) is a common valvular heart disease affecting >1.6 million people in the United States (US) and >70 million people worldwide. The age- and sex-adjusted prevalence of more than or equal to moderate TR in the US is estimated to be 0.55%. One-year mortality increases with increasing severity of TR. Yet, the majority of patients with severe TR are managed medically in the absence of another indication for cardiac surgery, and isolated tricuspid valve (TV) surgery remains infrequent. To address this unmet clinical need, various transcatheter TV therapies are now being developed as an alternative to surgery in extreme- and high-risk patients with severe functional TR. Transcatheter TV repair devices are aimed at improving leaflet coaptation either directly by bringing the leaflets together (leaflet/coaptation devices) or indirectly by repairing the dilated annulus (annuloplasty devices). In this review, we describe the current state of transcatheter TV repair therapies and summarize the available data on the efficacy and safety of various devices. Procedural and clinical outcomes of transcatheter TV repair therapies are expected to improve in the coming years with technological advancement, newer device iterations, and increased experience in this field. Appropriate patient selection, optimal timing of intervention, and evaluation of long-term outcomes and device durability will be key in ongoing and future studies.

Keywords: TV; Tricuspid regurgitation (TR); transcatheter tricuspid valve repair (transcatheter TV repair); tricuspid insufficiency.

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

2020 Cardiovascular Diagnosis and Therapy. All rights reserved.

References

    1. Demir OM, Regazzoli D, Mangieri A, et al. Transcatheter Tricuspid Valve Replacement: Principles and Design. Front Cardiovasc Med 2018;5:129. 10.3389/fcvm.2018.00129
    1. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897-902. 10.1016/S0002-9149(98)01064-9
    1. Topilsky Y, Maltais S, Medina IJ, et al. Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. JACC Cardiovasc Imaging 2019;12:433-42. 10.1016/j.jcmg.2018.06.014
    1. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405-9. 10.1016/j.jacc.2003.09.036
    1. Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg 2006;132:1258-61. 10.1016/j.jtcvs.2006.08.049
    1. Vassileva CM, Shabosky J, Boley T, et al. Tricuspid valve surgery: the past 10 years from the Nationwide Inpatient Sample (NIS) database. J Thorac Cardiovasc Surg 2012;143:1043-9. 10.1016/j.jtcvs.2011.07.004
    1. Kim JB, Jung SH, Choo SJ, et al. Clinical and echocardiographic outcomes after surgery for severe isolated tricuspid regurgitation. J Thorac Cardiovasc Surg 2013;146:278-84. 10.1016/j.jtcvs.2012.04.019
    1. Kwon DA, Park JS, Chang HJ, et al. Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity. Am J Cardiol 2006;98:659-61. 10.1016/j.amjcard.2006.03.047
    1. Zack CJ, Fender EA, Chandrashekar P, et al. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol 2017;70:2953-60. 10.1016/j.jacc.2017.10.039
    1. Rodés-Cabau J, Hahn RT, Latib A, et al. Transcatheter Therapies for Treating Tricuspid Regurgitation. J Am Coll Cardiol 2016;67:1829-45. 10.1016/j.jacc.2016.01.063
    1. Dahou A, Levin D, Reisman M, et al. Anatomy and Physiology of the Tricuspid Valve. JACC Cardiovasc Imaging 2019;12:458-68. 10.1016/j.jcmg.2018.07.032
    1. Fender EA, Zack CJ, Nishimura RA. Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart 2018;104:798-806. 10.1136/heartjnl-2017-311586
    1. Taramasso M, Alessandrini H, Latib A, et al. Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. JACC Cardiovasc Interv 2019;12:155-65. 10.1016/j.jcin.2018.10.022
    1. Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique. Circulation 2017;135:1802-14. 10.1161/CIRCULATIONAHA.116.024848
    1. Orban M, Besler C, Braun D, et al. Six-month outcome after transcatheter edge-to-edge repair of severe tricuspid regurgitation in patients with heart failure. Eur J Heart Fail 2018;20:1055-62. 10.1002/ejhf.1147
    1. Braun D, Nabauer M, Orban M, et al. One-year results of transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. EuroIntervention 2018;14:e413-5. 10.4244/EIJ-D-18-00186
    1. NCT03227757 Evaluation of Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation (TRILUMINATE). C. 12-18-2018. 1-18-2019.
    1. Fam NP, Ho EC, Zahrani M, et al. Transcatheter Tricuspid Valve Repair With the PASCAL System. JACC Cardiovasc Interv 2018;11:407-8. 10.1016/j.jcin.2017.12.004
    1. NCT03745313 Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study. 5-20-2019. . 6-4-2019.
    1. Perlman G, Praz F, Puri R, et al. Transcatheter Tricuspid Valve Repair With a New Transcatheter Coaptation System for the Treatment of Severe Tricuspid Regurgitation: 1-Year Clinical and Echocardiographic Results. JACC Cardiovasc Interv 2017;10:1994-2003. 10.1016/j.jcin.2017.06.036
    1. NCT02471807 Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System. 3-22-2018. . 1-18-2019.
    1. NCT02787408 The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System. 12-26-2017. . 1-18-2019.
    1. Nickenig G. TRI-REPAIR: 30-Day Outcomes of Transcatheter TV Repair in Patients With Severe Secondary Tricuspid Regurgitation. Transcatheter Cardiovascular Therapeutics 2017. 11-2-2017. Denver, CO. 11-2-2017.
    1. Nickenig G, Weber M, Schueler R, et al. 6-Month Outcomes of Tricuspid Valve Reconstruction for Patients With Severe Tricuspid Regurgitation. J Am Coll Cardiol 2019;73:1905-15. 10.1016/j.jacc.2019.01.062
    1. Kreidel F. 1-Year Outcomes of the TRI-REPAIR Study Assessing Cardioband Tricuspid Valve Reconstruction System for Patients With Functional Tricuspid Regurgitation. . 6-14-2019. 6-16-2019.
    1. Lim S. Results From the Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation. . 6-14-2019. 6-16-2019.
    1. NCT03779490 Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR Sytem Post Market Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic, Chronic Functional Tricuspid Regurgitation. 12-18-2018. . 7-4-2019.
    1. Zovighian BV. Transcatheter Mitral and Tricuspid Therapies. 12-5-2018. Edwards Lifesciences. 6-4-2019.
    1. Hahn RT, Meduri CU, Davidson CJ, Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results. J Am Coll Cardiol 2017;69:1795-806. 10.1016/j.jacc.2017.01.054
    1. NCT03225612 Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) (SCOUT-II). 2-7-2018. . 1-18-2019.
    1. NCT02098200 Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™ (PREVENT). 3-14-2018. . 1-18-2019.
    1. Giannini F, Colombo A. Percutaneous treatment of tricuspid valve in refractory right heart failure. Eur Heart J Suppl 2019;21:B43-7. 10.1093/eurheartj/suz031
    1. NCT03632967 Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System. 4-30-2019. . 7-4-2019.
    1. NCT03294200 Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System. 4-30-2019. . 7-4-2019.
    1. First Clinical Tricuspid Bicuspidization Procedure Completed Using Micro Interventional Devices' MIA Technology. 9-7-2017. Cardiac Interventions TODAY.
    1. NCT03700918 A First in Human Study to Assess Safety and Performance of the DaVingi™ TR System in the Treatment of Patients With Functional Tricuspid Regurgitation. 10-15-2018. . 7-4-2019.
    1. Kolte D, Elmariah S. Transcatheter Tricuspid Valve Therapy. Curr Treat Options Cardiovasc Med 2019;21:26. 10.1007/s11936-019-0730-7
    1. Braun D, Orban M, Orban M, et al. Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation Using the Triple-Orifice Technique Versus the Bicuspidalization Technique. JACC Cardiovasc Interv 2018;11:1790-2. 10.1016/j.jcin.2018.05.049
    1. Orban M, Braun D, Deseive S, et al. Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation Is Associated With Right Ventricular Reverse Remodeling in Patients With Right-Sided Heart Failure. JACC Cardiovasc Imaging 2019;12:559-60. 10.1016/j.jcmg.2018.10.029
    1. Ledwoch J, Fellner C, Poch F, et al. Reverse Cardiac Remodeling After Transcatheter Treatment of Severe Tricuspid Regurgitation Using the Edge-to-Edge MitraClip Technique. J Invasive Cardiol 2019;31:89-93.
    1. Karam N, Braun D, Mehr M, et al. Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function. JACC Cardiovasc Interv 2019;12:1413-20. 10.1016/j.jcin.2019.04.018
    1. Praz F, Spargias K, Chrissoheris M, et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 2017;390:773-80. 10.1016/S0140-6736(17)31600-8
    1. Puri R, Rodes-Cabau J. The FORMA Repair System. Interv Cardiol Clin 2018;7:47-55. 10.1016/j.iccl.2017.08.007
    1. Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J 2019;40:466-72. 10.1093/eurheartj/ehy424
    1. Mangieri A, Lim S, Rogers JH, et al. Percutaneous Tricuspid Annuloplasty. Interv Cardiol Clin 2018;7:31-6. 10.1016/j.iccl.2017.08.006
    1. Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy. 4-30-2018. Irvine, CA, Edwards Lifesciences, Inc. 1-18-2019.
    1. Schofer J, Bijuklic K, Tiburtius C, et al. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol 2015;65:1190-5. 10.1016/j.jacc.2015.01.025
    1. Kay JH, Maselli-Campagna G, Tsuji KK. Surgical treatment of tricuspid insufficiency. Ann Surg 1965;162:53-8. 10.1097/00000658-196507000-00009
    1. Ghanta RK, Chen R, Narayanasamy N, et al. Suture bicuspidization of the tricuspid valve versus ring annuloplasty for repair of functional tricuspid regurgitation: midterm results of 237 consecutive patients. J Thorac Cardiovasc Surg 2007;133:117-26. 10.1016/j.jtcvs.2006.08.068
    1. Besler C, Meduri CU, Lurz P. Transcatheter Treatment of Functional Tricuspid Regurgitation Using the Trialign Device. Interv Cardiol 2018;13:8-13. 10.15420/icr.2017:21:1
    1. Rosser BA, Taramasso M, Maisano F. Transcatheter interventions for tricuspid regurgitation: TriCinch (4Tech). EuroIntervention 2016;12:Y110-2. 10.4244/EIJV12SYA30
    1. Rogers T, Ratnayaka K, Sonmez M, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv 2015;8:483-91. 10.1016/j.jcin.2014.10.013
    1. Khan JM, Rogers T, Schenke WH, et al. Transcatheter pledget-assisted suture tricuspid annuloplasty (PASTA) to create a double-orifice valve. Catheter Cardiovasc Interv 2018;92:E175-84. 10.1002/ccd.27531
    1. Hetzer R, Javier M, Delmo Walter EM. The Double-Orifice Valve Technique to Treat Tricuspid Valve Incompetence. J Heart Valve Dis 2016;25:66-71.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner